Study S000294

A Multi-centre, Prospective, Non-interventional, Single-armed, 104 Weeks Post-marketing Study to Investigate Safety and Clinical Parameters of Wegovy® Once Weekly in Patients With Obesity Disease Under Real-world Clinical Practice Conditions

ClinicalTrials.gov record

Registration

Registration: NCT06283667
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 1071
Start: 2024-06-11
Primary completion: 2028-01-31
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1266-3863

Registered primary outcomes

Number of Adverse Reactions (ARs) [From baseline (week 0) to end of study (week 104)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.